Pharmaceutical trademarks

The third amendment to the Trademark Law, which will take effect on May 1 2014, has brought about changes to both the procedural and substantive aspects of trademark practice in China, and some may influence the protection of pharmaceutical marks. Since the law has not yet come into effect, the cases cited here were all decided under the law before its amendment, but this article also discusses potential expected changes to similar cases in future.


Unlock unlimited access to all WTR content